1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Prusagliflozin Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 7 Tablets Per Box
  • 1.3.3 14 Tablets Per Box
• 1.4 Market Analysis by Combination Therapy
  • 1.4.1 Overview: Global Prusagliflozin Tablets Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
  • 1.4.2 Combination With Metformin
  • 1.4.3 Combination With Sglt-2 Inhibitors
• 1.5 Market Analysis by Sales Channels
  • 1.5.1 Overview: Global Prusagliflozin Tablets Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
  • 1.5.2 Hospitals
  • 1.5.3 Retail
  • 1.5.4 Online
• 1.6 Market Analysis by Application
  • 1.6.1 Overview: Global Prusagliflozin Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.6.2 Treatment Of Type 2 Diabetes Mellitus
  • 1.6.3 Improvement Of Glycemic Control
  • 1.6.4 Adjuvant Therapy For Diabetic Complications
  • 1.6.5 Others
• 1.7 Global Prusagliflozin Tablets Market Size & Forecast
  • 1.7.1 Global Prusagliflozin Tablets Consumption Value (2021 & 2025 & 2032)
  • 1.7.2 Global Prusagliflozin Tablets Sales Quantity (2021-2032)
  • 1.7.3 Global Prusagliflozin Tablets Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 CSPC Ouyi Pharmaceutical
  • 2.1.1 CSPC Ouyi Pharmaceutical Details
  • 2.1.2 CSPC Ouyi Pharmaceutical Major Business
  • 2.1.3 CSPC Ouyi Pharmaceutical Prusagliflozin Tablets Product and Services
  • 2.1.4 CSPC Ouyi Pharmaceutical Prusagliflozin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Prusagliflozin Tablets by Manufacturer

• 3.1 Global Prusagliflozin Tablets Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Prusagliflozin Tablets Revenue by Manufacturer (2021-2026)
• 3.3 Global Prusagliflozin Tablets Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Prusagliflozin Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Prusagliflozin Tablets Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Prusagliflozin Tablets Manufacturer Market Share in 2025
• 3.5 Prusagliflozin Tablets Market: Overall Company Footprint Analysis
  • 3.5.1 Prusagliflozin Tablets Market: Region Footprint
  • 3.5.2 Prusagliflozin Tablets Market: Company Product Type Footprint
  • 3.5.3 Prusagliflozin Tablets Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Prusagliflozin Tablets Market Size by Region
  • 4.1.1 Global Prusagliflozin Tablets Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Prusagliflozin Tablets Consumption Value by Region (2021-2032)
  • 4.1.3 Global Prusagliflozin Tablets Average Price by Region (2021-2032)
• 4.2 North America Prusagliflozin Tablets Consumption Value (2021-2032)
• 4.3 Europe Prusagliflozin Tablets Consumption Value (2021-2032)
• 4.4 Asia-Pacific Prusagliflozin Tablets Consumption Value (2021-2032)
• 4.5 South America Prusagliflozin Tablets Consumption Value (2021-2032)
• 4.6 Middle East & Africa Prusagliflozin Tablets Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Prusagliflozin Tablets Sales Quantity by Type (2021-2032)
• 5.2 Global Prusagliflozin Tablets Consumption Value by Type (2021-2032)
• 5.3 Global Prusagliflozin Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Prusagliflozin Tablets Sales Quantity by Application (2021-2032)
• 6.2 Global Prusagliflozin Tablets Consumption Value by Application (2021-2032)
• 6.3 Global Prusagliflozin Tablets Average Price by Application (2021-2032)

7 North America

• 7.1 North America Prusagliflozin Tablets Sales Quantity by Type (2021-2032)
• 7.2 North America Prusagliflozin Tablets Sales Quantity by Application (2021-2032)
• 7.3 North America Prusagliflozin Tablets Market Size by Country
  • 7.3.1 North America Prusagliflozin Tablets Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Prusagliflozin Tablets Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Prusagliflozin Tablets Sales Quantity by Type (2021-2032)
• 8.2 Europe Prusagliflozin Tablets Sales Quantity by Application (2021-2032)
• 8.3 Europe Prusagliflozin Tablets Market Size by Country
  • 8.3.1 Europe Prusagliflozin Tablets Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Prusagliflozin Tablets Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Prusagliflozin Tablets Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Prusagliflozin Tablets Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Prusagliflozin Tablets Market Size by Region
  • 9.3.1 Asia-Pacific Prusagliflozin Tablets Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Prusagliflozin Tablets Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Prusagliflozin Tablets Sales Quantity by Type (2021-2032)
• 10.2 South America Prusagliflozin Tablets Sales Quantity by Application (2021-2032)
• 10.3 South America Prusagliflozin Tablets Market Size by Country
  • 10.3.1 South America Prusagliflozin Tablets Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Prusagliflozin Tablets Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Prusagliflozin Tablets Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Prusagliflozin Tablets Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Prusagliflozin Tablets Market Size by Country
  • 11.3.1 Middle East & Africa Prusagliflozin Tablets Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Prusagliflozin Tablets Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Prusagliflozin Tablets Market Drivers
• 12.2 Prusagliflozin Tablets Market Restraints
• 12.3 Prusagliflozin Tablets Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Prusagliflozin Tablets and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Prusagliflozin Tablets
• 13.3 Prusagliflozin Tablets Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Prusagliflozin Tablets Typical Distributors
• 14.3 Prusagliflozin Tablets Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Prusagliflozin Tablets market size was valued at US$ 15.43 million in 2025 and is forecast to a readjusted size of US$ 82.64 million by 2032 with a CAGR of 5.0% during review period.
Prusagliptin is a novel, highly selective dipeptidyl peptidase‑4 inhibitor developed for the treatment of type 2 diabetes mellitus. It exerts its hypoglycemic effect by inhibiting DPP‑4 enzyme activity, thereby slowing the degradation of incretin hormones, enhancing glucose‑dependent insulin secretion, and suppressing glucagon release to regulate blood glucose levels in a physiological manner. With good oral bioavailability and favorable safety profile, it is administered orally as a single daily dose, either alone or in combination with other antidiabetic agents, to improve glycemic control in adult patients with type 2 diabetes.In 2025, global Prusogliptin production reached approximately 12–18 million bottles.
Prusogliptin operates within the competitive landscape of the global DPP-4 inhibitor market, where it carves out a distinct position as a novel, domestically developed therapeutic option. As a new entrant, it competes with several established agents, differentiating itself primarily through its optimized chemical structure, which confers high enzyme selectivity and a favorable pharmacokinetic profile. This positions it well for patients requiring multiple concomitant medications, as its low potential for drug-drug interactions enhances its clinical utility in complex comorbid populations. The market environment is characterized by a persistent, underlying demand driven by the rising global prevalence of type 2 diabetes, balanced against intense competition from both branded and generic alternatives, as well as the growing market share of newer drug classes like SGLT-2 inhibitors and GLP-1 receptor agonists. Despite these pressures, Prusogliptin benefits from strategic market positioning, leveraging its innovative profile and the expansion of the developer's product pipeline, including upcoming combination therapies, to secure a foothold and drive future growth within the evolving diabetes treatment ecosystem.
This report is a detailed and comprehensive analysis for global Prusagliflozin Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prusagliflozin Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Prusagliflozin Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Prusagliflozin Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Prusagliflozin Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prusagliflozin Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prusagliflozin Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSPC Ouyi Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Prusagliflozin Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
7 Tablets Per Box
14 Tablets Per Box
Market segment by Combination Therapy
Combination With Metformin
Combination With Sglt-2 Inhibitors
Market segment by Sales Channels
Hospitals
Retail
Online
Market segment by Application
Treatment Of Type 2 Diabetes Mellitus
Improvement Of Glycemic Control
Adjuvant Therapy For Diabetic Complications
Others
Major players covered
CSPC Ouyi Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prusagliflozin Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prusagliflozin Tablets, with price, sales quantity, revenue, and global market share of Prusagliflozin Tablets from 2021 to 2026.
Chapter 3, the Prusagliflozin Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prusagliflozin Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Prusagliflozin Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prusagliflozin Tablets.
Chapter 14 and 15, to describe Prusagliflozin Tablets sales channel, distributors, customers, research findings and conclusion.